Recombinant protein of human abl-interactor 1 (ABI1), transcript variant 4, 20 µg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Proteins
Recombinant protein of human complement component 4 binding protein, alpha (C4BPA), 20 µg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Recombinant protein of human barrier to autointegration factor 1 (BANF1), transcript variant 1, 20 µg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Recombinant protein of human nucleoredoxin-like 1 (NXNL1), 20 µg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Transient overexpression lysate of v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) (ERBB2), transcript variant 1
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Recombinant protein of human epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian) (EGFR), full length, with C-terminal DDK tag, expressed in sf9 cells
| Tag | C-DDK |
| Expression Host | Sf9 |
Purified recombinant protein of Human forkhead box O4 (FOXO4), transcript variant 1, full length, with N-terminal HIS tag, expressed in E.Coli, 50ug
| Tag | N-His |
| Expression Host | E. coli |
Recombinant protein of human poly(rC) binding protein 3 (PCBP3), transcript variant 1, 20 µg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Recombinant protein of human chromosome 21 open reading frame 56 (C21orf56), transcript variant 2, 20 µg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Recombinant protein of human inhibitor of DNA binding 3, dominant negative helix-loop-helix protein (ID3), 20 µg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Recombinant protein of human abl-interactor 1 (ABI1), transcript variant 1, 20 µg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Recombinant protein of human CASP2 and RIPK1 domain containing adaptor with death domain (CRADD), 20 µg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Recombinant protein of human cellular repressor of E1A-stimulated genes 1 (CREG1), 20 µg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Recombinant protein of human peptidylprolyl cis/trans isomerase, NIMA-interacting 1 (PIN1), 20 µg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Recombinant protein of human N-acetylneuraminic acid synthase (NANS), 20 µg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
活动过滤器
优化搜索结果
Species
Target Symbol
- P53 (7)
- EGFR (5)
- HER2 (5)
- HTRA1 (5)
- SLC14A1 (5)
- CALRETICULIN (4)
- CD44 (4)
- E2F1 (4)
- FOXO3 (4)
- IGF1 RECEPTOR (4)
- ISOCITRATE DEHYDROGENASE (4)
- OCT4 (4)
- OSTEOPONTIN (4)
- RUNX1 (4)
- VEGFC (4)
- ALKALINE PHOSPHATASE (3)
- AMYLOID PRECURSOR PROTEIN (3)
- ASRGL1 (3)
- B RAF (3)
- BETA CATENIN (3)
- C-MYC (3)
- CABS1 (3)
- CD133 (3)
- CLUSTERIN (3)
- CREG1 (3)
- CTLA4 (3)
- DICER (3)
- DNMT1 (3)
- DR5 (3)
- DRP1 (3)
- EFEMP1 (3)
- EGR1 (3)
- EMA (3)
- ESTROGEN RECEPTOR 1 (3)
- EZH2 (3)
- FGF2 (3)
- FGFR4 (3)
- FIBROMODULIN (3)
- FLT1 (3)
- FOXO1 (3)
- G PROTEIN ALPHA S (3)
- GAPDH (3)
- GDI2 (3)
- GPR56 (3)
- IL1 BETA (3)
- KDR (3)
- KEAP1 (3)
- LRRC32 (3)
- MITF (3)
- N PROTEIN (3)
- NCF1 (3)
- NUCLEOPHOSMIN (3)
- P63 (3)
- PD-L1 (3)
- PDPN (3)
- PROTEIN C (3)
- PTEN (3)
- S PROTEIN (3)
- SAMHD1 (3)
- SATB1 (3)
- SGPL1 (3)
- SOX2 (3)
- STAT3 (3)
- TCF4 (3)
- TRIM21 (3)
- XRCC4 (3)
- ZSCAN4 (3)
- ADAR1 (2)
- ADIPONECTIN RECEPTOR 1 (2)
- AKIRIN2 (2)
- ALDH1A1 (2)
- ALDH3A1 (2)
- ALPHA ACTININ 4 (2)
- ALPHA TUBULIN (2)
- AMFR (2)
- AMINO TERMINAL ENHANCER OF SPLIT (2)
- ANKRD2 (2)
- AP2 ALPHA (2)
- APE1 (2)
- APOBEC3G (2)
- AQUAPORIN 3 (2)
- ARGONAUTE 2 (2)
- AROMATASE (2)
- ATG16L1 (2)
- BCAT1 (2)
- BMI1 (2)
- BMP2 (2)
- BREAST CANCER SUPPRESSOR CANDIDATE 1 (2)
- BTN3A2 (2)
- C REACTIVE PROTEIN (2)
- C20ORF114 (2)
- C5R1 (2)
- CALPAIN 2 (2)
- CAMK2G (2)
- CAVEOLIN 1 (2)
- CCK4 (2)
- CD117 (2)
- CD18 (2)
- CD33 (2)
- CD5 (2)
Expression Hosts
Tags
- C-Myc/DDK (1602)
- N-His (103)
- C-MYC/DDK (90)
- C-His (33)
- C-DDK (26)
- Tag Free (18)
- N-GST and C-His (10)
- C-DDK/His (6)
- Myc-DDK (4)
- C-HIS (3)
- His-tag (3)
- N-HIS (2)
- N-His-ABP (Albumin-Binding Protein) (2)
- N-T7&C-His (2)
- C- 6×His (1)
- C-6His (1)
- C-6xHis (1)
- C-6xHis/AVI (1)
- C-Fc (1)
- N-10*His (1)
- N-DDK (1)
- N-GST/C-His (1)
- N-His&C-His (1)
- N-His/DDK (1)
- N-terminal His (1)
- N-terminal murine Fc Tag (1)
Conjugates
Mutants
Brands
QC Levels
Families
- WB (722)
- Druggable Genome (695)
- Transmembrane (200)
- Transcription Factors (179)
- Secreted Protein (174)
- ES Cell Differentiation/IPS (100)
- Protein Kinase (80)
- Stem cell - Pluripotency (60)
- Protease (43)
- Adult stem cells (27)
- Embryonic stem cells (21)
- Phosphatase (18)
- Cancer stem cells (16)
- Induced pluripotent stem cells (15)
- Nuclear Hormone Receptor (14)
- Stem cell relevant signaling - JAK/STAT signaling pathway (12)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (8)
- Stem cell relevant signaling - DSL/Notch pathway (5)
- Stem cell relevant signaling - Wnt Signaling pathway (5)
- GPCR (4)
- Ion Channels: Other (3)
- P450 (3)
- 10 mM Tris-HCl (2)
- 2 mM dithiothreitol (2)
-
ELISA.
Western Blot. (2) - Ion Channels: Glutamate Receptors (2)
- the solution can be further dialyzed against PBS (phosphate buffered saline (2)
- 000) as well as other antibody based fluorescent assays. (1)
-
000)
Flow Cytometry/FACS (1/1 (1) - 000-1/5 (1)
- 10mM Tris-HCl (1)
- 2mM dithiothreitol (1)
-
ELISA.
Western Blot.
Cell culture and/or animal studies. (1) -
ELISA.
Suitable for use as a Control or standard in indirect trapping ELISA for quantitation of antigen in serum using a standard curve.
Immunoprecipitation.
Western blotting. (1) - ELISA: this protein is suitable for use as a Mouse IgE standard in ELISA assays. (1)
- Functional Assays. (1)
-
Protein standard in 1D and 2D SDS gelelectrophoresis.
Immunoassays.
Immunization.
Protocol: Reconstitution to filaments: After vimentin is dissolved in 9.5M Urea buffer (see above) (1) -
Protein standard in 1D and 2D SDS gelelectrophoresis.
Immunoassays.
Immunization.
Protocol: Reconstitution to filaments is performed by mixing equimolar amounts of keratins of type I and type II at concentrations of approx. 0.5 mg/ml (1) - Can be used as standard in a Sandwich ELISA. (1)
- ELISA (1)
-
For use as a Control or standard in indirect trapping ELISA for quantitation of antigen in serum using a standard curve.
Immunoprecipitation.
Western blotting. (1) - Immunofluorescence Microscopy (1/1 (1)
- Ion Channels: Potassium (1)
-
Protein standard in 1D and 2D SDS gelelectrophoresis.
Immunoassays.
Immunization.
Protocol: Reconstitution to filaments is performed by mixing equimolar amounts of keratins of type I and type II at concentrations of approx. 0.5 mg/ml (1) - Specific methodologies have not been tested using this product. (1)
-
both dissolved in 9.5 M urea buffer (see above).
Protofilaments and filament complexes are obtained by dialyzing the resulting polypeptide solution stepwise to a concentration of 4 M urea and then to low salt condition (50 mM NaCl (1) - both dissolved in 9.5 M urea buffer (see above). Protofilaments and filament complexes are obtained by dialyzing the resulting polypeptide solution stepwise to a concentration of 4 M urea and then to low salt condition (50 mM NaCl (1)
- e.g. Dulbecco's PBS). (1)
-
e.g. Dulbeccos PBS).
See References 2 and 3 for more details. (1) - e.g.Dulbecco's PBS). (1)
-
pH 7.4).
For immunization purposes (1) -
pH 7.4).
For Immunization purposes (1) -
pH 7.4).
For immunization purposes (1) - protofilaments and filament complexes are obtained by dialyzing the resulting polypeptide solution stepwise to a concentration of 4M Urea and then to low salt condition (50mM NaCl (1)
- the solution can be further dialyzed against PBS (Phosphate Buffered Saline (1)
Pathways
- Pathways in cancer (167)
- Metabolic pathways (146)
- Focal adhesion (107)
- MAPK signaling pathway (94)
- Regulation of actin cytoskeleton (82)
- Prostate cancer (76)
- Endocytosis (74)
- Cytokine-cytokine receptor interaction (71)
- Pancreatic cancer (60)
- Melanoma (59)
- Chemokine signaling pathway (58)
- Endometrial cancer (57)
- Chronic myeloid leukemia (55)
- Bladder cancer (53)
- Colorectal cancer (51)
- Glioma (51)
- ErbB signaling pathway (50)
- Insulin signaling pathway (49)
- Neurotrophin signaling pathway (49)
- Non-small cell lung cancer (48)
- Natural killer cell mediated cytotoxicity (46)
- Renal cell carcinoma (46)
- Small cell lung cancer (46)
- Adherens junction (44)
- T cell receptor signaling pathway (44)
- Acute myeloid leukemia (43)
- Apoptosis (43)
- Wnt signaling pathway (43)
- Cell cycle (42)
- Toll-like receptor signaling pathway (40)
- Fc gamma R-mediated phagocytosis (39)
- Jak-STAT signaling pathway (38)
- Leukocyte transendothelial migration (38)
- Hematopoietic cell lineage (37)
- Alzheimer's disease (36)
- Cell adhesion molecules (CAMs) (36)
- TGF-beta signaling pathway (35)
- p53 signaling pathway (35)
- Melanogenesis (34)
- Fc epsilon RI signaling pathway (33)
- Progesterone-mediated oocyte maturation (33)
- Axon guidance (32)
- Tight junction (32)
- Huntington's disease (30)
- Oocyte meiosis (30)
- Thyroid cancer (30)
- Ubiquitin mediated proteolysis (30)
- VEGF signaling pathway (30)
- Pathogenic Escherichia coli infection (29)
- Calcium signaling pathway (28)
- B cell receptor signaling pathway (27)
- Gap junction (27)
- GnRH signaling pathway (27)
- Long-term depression (27)
- RIG-I-like receptor signaling pathway (27)
- Long-term potentiation (26)
- mTOR signaling pathway (25)
- Adipocytokine signaling pathway (24)
- Amyotrophic lateral sclerosis (ALS) (24)
- Cytosolic DNA-sensing pathway (23)
- NOD-like receptor signaling pathway (23)
- Neuroactive ligand-receptor interaction (23)
- Basal cell carcinoma (22)
- PPAR signaling pathway (22)
- Vascular smooth muscle contraction (22)
- Antigen processing and presentation (21)
- Viral myocarditis (21)
- Spliceosome (20)
- Epithelial cell signaling in Helicobacter pylori infection (19)
- Glycolysis / Gluconeogenesis (19)
- Lysosome (19)
- Type I diabetes mellitus (19)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (18)
- Complement and coagulation cascades (18)
- Dilated cardiomyopathy (18)
- ECM-receptor interaction (18)
- Hypertrophic cardiomyopathy (HCM) (18)
- Prion diseases (18)
- Type II diabetes mellitus (18)
- Purine metabolism (17)
- Graft-versus-host disease (15)
- Glutathione metabolism (13)
- Notch signaling pathway (13)
- Parkinson's disease (13)
- Citrate cycle (TCA cycle) (12)
- Dorso-ventral axis formation (12)
- Metabolism of xenobiotics by cytochrome P450 (12)
- Pyrimidine metabolism (12)
- Systemic lupus erythematosus (12)
- Allograft rejection (11)
- Arginine and proline metabolism (11)
- Base excision repair (11)
- Hedgehog signaling pathway (11)
- Vibrio cholerae infection (11)
- Autoimmune thyroid disease (10)
- Cysteine and methionine metabolism (10)
- DNA replication (10)
- Pyruvate metabolism (10)
- Tryptophan metabolism (10)
- Arachidonic acid metabolism (9)
- Drug metabolism - cytochrome P450 (9)
- Inositol phosphate metabolism (9)
- Phosphatidylinositol signaling system (9)
- Sphingolipid metabolism (9)
- Valine (9)
- Butanoate metabolism (8)
- Fructose and mannose metabolism (8)
- Regulation of autophagy (8)
- Retinol metabolism (8)
- leucine and isoleucine degradation (8)
- Alanine (7)
- Glycerophospholipid metabolism (7)
- Maturity onset diabetes of the young (7)
- Nucleotide excision repair (7)
- aspartate and glutamate metabolism (7)
- Asthma (6)
- Drug metabolism - other enzymes (6)
- Glycosaminoglycan degradation (6)
- Histidine metabolism (6)
- Homologous recombination (6)
- Nicotinate and nicotinamide metabolism (6)
- Non-homologous end-joining (6)
- Other glycan degradation (6)
- SNARE interactions in vesicular transport (6)
- Starch and sucrose metabolism (6)
- Amino sugar and nucleotide sugar metabolism (5)
- Cardiac muscle contraction (5)
- Glycerolipid metabolism (5)
- Glycine (5)
- Lysine degradation (5)
- Oxidative phosphorylation (5)
- Proteasome (5)
- Renin-angiotensin system (5)
- beta-Alanine metabolism (5)
- serine and threonine metabolism (5)
- Androgen and estrogen metabolism (4)
- Fatty acid metabolism (4)
- Galactose metabolism (4)
- Linoleic acid metabolism (4)
- Pentose phosphate pathway (4)
- Porphyrin and chlorophyll metabolism (4)
- Primary immunodeficiency (4)
- Tyrosine metabolism (4)
- ABC transporters (3)
- Aminoacyl-tRNA biosynthesis (3)
- Ascorbate and aldarate metabolism (3)
- C21-Steroid hormone metabolism (3)
- Ether lipid metabolism (3)
- Folate biosynthesis (3)
- Glycosphingolipid biosynthesis - lacto and neolacto series (3)
- Mismatch repair (3)
- Nitrogen metabolism (3)
- Olfactory transduction (3)
- Phenylalanine metabolism (3)
- Propanoate metabolism (3)
- RNA degradation (3)
- Ribosome (3)
- Taste transduction (3)
- Biosynthesis of unsaturated fatty acids (2)
- Chondroitin sulfate biosynthesis (2)
- Fatty acid elongation in mitochondria (2)
- Glycosphingolipid biosynthesis - globo series (2)
- Glyoxylate and dicarboxylate metabolism (2)
- Limonene and pinene degradation (2)
- Methane metabolism (2)
- One carbon pool by folate (2)
- Pentose and glucuronate interconversions (2)
- Primary bile acid biosynthesis (2)
- Selenoamino acid metabolism (2)
- Synthesis and degradation of ketone bodies (2)
- Taurine and hypotaurine metabolism (2)
- Terpenoid backbone biosynthesis (2)
- Vitamin B6 metabolism (2)
- alpha-Linolenic acid metabolism (2)
- leucine and isoleucine biosynthesis (2)
- Basal transcription factors (1)
- Caffeine metabolism (1)
- Circadian rhythm - mammal (1)
- Cyanoamino acid metabolism (1)
- D-Arginine and D-ornithine metabolism (1)
- D-Glutamine and D-glutamate metabolism (1)
- Glycosphingolipid biosynthesis - ganglio series (1)
- Glycosylphosphatidylinositol(GPI)-anchor biosynthesis (1)
- Heparan sulfate biosynthesis (1)
- O-Glycan biosynthesis (1)
- O-Mannosyl glycan biosynthesis (1)
- Pantothenate and CoA biosynthesis (1)
- Protein export (1)
- Thiamine metabolism (1)
